In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to detect safe dosing regimen. More contributors is going to be enrolled within the identified monotherapy dosign regimen. In Section B, members will acquire oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section https://victorl776amx0.ltfblog.com/profile